BDBM429988 2-({4-[N-(3-bromo-4- fluorophenyl)-N'- hydroxycarbamimidoyl]-1,2.5- oxadiazol-3-yl}sulfanyl)-N- [(1r,3R,4S)-3,4- dihydroxycyclopentyl]acetamide::US10538497, Example 177

SMILES O\N=C(/Nc1ccc(F)c(Br)c1)c1nonc1SCC(=O)N[C@@H]1C[C@H](O)[C@H](O)C1

InChI Key InChIKey=GYIZRWQBXGKUFO-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 429988   

TargetIndoleamine 2,3-dioxygenase 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM429988(US10538497, Example 177 | 2-({4-[N-(3-bromo-4- flu...)
Affinity DataIC50: 97.3nMAssay Description:HIS-tagged IDO1 protein was recombinantly expressed in Escherichia coli using ZYP5052 autoinduction media supplemented with 500 uM delta aminolevulin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/9/2020
Entry Details
US Patent